Princeton, NJ, United States of America

Percy H Carter

This inventor holds 35 USPTO granted patents and 3 published patent applications and 19 EPO patents, primarily in Chemokine Receptor Modulation. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007-2024.

USPTO Granted Patents = 35 

% Patents Active = 94.3

 

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 125(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Chemokine Receptor
Piperidinyl Derivatives
Macrocyclic Peptides
Cyclic Derivatives
Prodrugs
Benzylpyrrolidinone
Hydroxyalkanyl Amides
Polynucleotides
Malonamide Derivatives
Substituted Bicyclic Amines
Lactams
N-Alkylated Diaminopropane
35 patents (USPTO):Explore Patents

Title: The Legacy of Percy H Carter: Innovator from Princeton

Introduction: Percy H Carter, a distinguished inventor hailing from Princeton, NJ, has made significant contributions to the field of technology and innovation.

Latest Patents: Percy H Carter's latest patents include groundbreaking inventions in the realm of renewable energy and sustainable materials, showcasing his commitment to environmental conservation.

Career Highlights: Throughout his illustrious career, Percy H Carter has been recognized for his pioneering work in the development of cutting-edge technologies that have revolutionized various industries. His innovative spirit and dedication to progress have set him apart as a visionary in the field of invention.

Collaborations: Percy H Carter has collaborated with leading research institutions, universities, and companies to bring his ideas to life. His partnerships have been instrumental in the successful implementation of his inventions on a global scale.

Conclusion: Percy H Carter's impact on the world of innovation is undeniable, and his legacy as an inventor continues to inspire future generations to push the boundaries of what is possible in the realm of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…